FDA Inspection 599709 — Frontida BioPharm Inc
The FDA completed an inspection of Frontida BioPharm Inc on Jun 30, 2009 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)